Strand Therapeutics is a biotech startup developing drugs to treat cancer. We developed a drug candidate made of mRNA that can make cancers more responsive to immunotherapy. Once our drug is administered to a patient, the tumors become more noticeable to the immune system and can now be attacked. We additionally developed a new synthetic mRNA programming technology to make our drug candidate safer than other gene therapies, more effective in patients, and cheaper and easier to manufacture.
Connect with Strand Therapeutics